NewGenIvf (NIVFW) Income from Continuing Operations (2024 - 2025)

NewGenIvf (NIVFW) posted quarterly Income from Continuing Operations of 7717290.0 for Q4 2025, down 1322.06% YoY from 631498.65 in Q4 2024, and down 146.08% sequentially from 16747981.0 in Q3 2025.

NewGenIvf (NIVFW) Income from Continuing Operations (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Income from Continuing Operations across 2 years of filings, most recently posting 7717290.0 for Q4 2025.

  • In Q4 2025, Income from Continuing Operations fell 1322.06% year-over-year to 7717290.0; the TTM figure through Dec 2025 stood at 8457665.0 (changed N/A YoY), while the FY2025 annual figure was 9728723.0, up 2152.04% from the prior year.
  • Income from Continuing Operations fell to 7717290.0 in Q4 2025, from 16747981.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for NIVFW reached as high as 16747981.0 in Q3 2025 and fell as low as 7717290.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 1.86 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 66.30 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 906.00 Mn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 275.04 Mn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 232.30 Mn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 99.76 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 358.68 Mn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 80.67 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn -1.11 Bn
10 NewGenIvf - - 524,025.00 -7.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.72 Mn
Sep 30, 2025 16.75 Mn
Dec 31, 2024 -542,684.00
Sep 30, 2024 -30,342.00